Rates by insurance carrier
| Insurance Carrier | Facility/Professional | Modifier | Typical Low | Median | Typical High |
|---|
Hawaii rates for HCPCS 0325U
Helps choose treatment for ovarian cancer by growing the patient's own cancer cells in the laboratory and exposing them to four targeted drugs, niraparib, olaparib, rucaparib and veliparib, to see which the cells respond to. The result is reported as a classification of likely response. A companion test does the same with chemotherapy drugs instead.
Rates data updated July 2026.
| Insurance Carrier | Facility/Professional | Modifier | Typical Low | Median | Typical High |
|---|